176 related articles for article (PubMed ID: 25714613)
1. The immune suppressive function of transforming growth factor-β (TGF-β) in human diseases.
Sheng J; Chen W; Zhu HJ
Growth Factors; 2015 Apr; 33(2):92-101. PubMed ID: 25714613
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.
Sanjabi S; Oh SA; Li MO
Cold Spring Harb Perspect Biol; 2017 Jun; 9(6):. PubMed ID: 28108486
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta: recent advances on its role in immune tolerance.
Mantel PY; Schmidt-Weber CB
Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
[TBL] [Abstract][Full Text] [Related]
4. Roles of the protein tyrosine phosphatase PTPN22 in immunity and autoimmunity.
Fousteri G; Liossis SN; Battaglia M
Clin Immunol; 2013 Dec; 149(3):556-65. PubMed ID: 24269925
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
Wrzesinski SH; Wan YY; Flavell RA
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta: recent advances on its role in immune tolerance.
Kriegel MA; Li MO; Sanjabi S; Wan YY; Flavell RA
Curr Rheumatol Rep; 2006 Apr; 8(2):138-44. PubMed ID: 16569373
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta regulation of immune responses.
Li MO; Wan YY; Sanjabi S; Robertson AK; Flavell RA
Annu Rev Immunol; 2006; 24():99-146. PubMed ID: 16551245
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.
Huang XL; Zhang L; Li JP; Wang YJ; Duan Y; Wang J
Autoimmunity; 2015; 48(8):503-10. PubMed ID: 26287504
[TBL] [Abstract][Full Text] [Related]
9. The role of TGF-beta signaling in dendritic cell tolerance.
Esebanmen GE; Langridge WHR
Immunol Res; 2017 Oct; 65(5):987-994. PubMed ID: 28845509
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
Prud'homme GJ; Piccirillo CA
J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma.
Laouar Y; Sutterwala FS; Gorelik L; Flavell RA
Nat Immunol; 2005 Jun; 6(6):600-7. PubMed ID: 15852008
[TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor-β Signaling in Immunity and Cancer.
Batlle E; Massagué J
Immunity; 2019 Apr; 50(4):924-940. PubMed ID: 30995507
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
14. Cotransfection with IL-10 and TGF-β1 into immature dendritic cells enhances immune tolerance in a rat liver transplantation model.
Chen L; Zheng L; He W; Qiu M; Gao L; Liu J; Huang A
Am J Physiol Gastrointest Liver Physiol; 2014 Apr; 306(7):G575-81. PubMed ID: 24503768
[TBL] [Abstract][Full Text] [Related]
15. The suppressive function of human CD8(+) iTregs is inhibited by IL-1β and TNFα.
Bjarnadottir U; Lemarquis AL; Halldorsdottir S; Freysdottir J; Ludviksson BR
Scand J Immunol; 2014 Nov; 80(5):313-22. PubMed ID: 25039313
[TBL] [Abstract][Full Text] [Related]
16. The TGF-β superfamily in dendritic cell biology.
Seeger P; Musso T; Sozzani S
Cytokine Growth Factor Rev; 2015 Dec; 26(6):647-57. PubMed ID: 26115564
[TBL] [Abstract][Full Text] [Related]
17. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
[TBL] [Abstract][Full Text] [Related]
18. Impaired TGF-β signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL-22.
Rekik R; Smiti Khanfir M; Larbi T; Zamali I; Beldi-Ferchiou A; Kammoun O; Marzouki S; Hamzaoui S; Mrad S; Barbouche MR; Houman MH; Ben Ahmed M
Cytokine; 2018 Aug; 108():182-189. PubMed ID: 29684755
[TBL] [Abstract][Full Text] [Related]
19. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
[TBL] [Abstract][Full Text] [Related]
20. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
Valenti R; Huber V; Filipazzi P; Pilla L; Sovena G; Villa A; Corbelli A; Fais S; Parmiani G; Rivoltini L
Cancer Res; 2006 Sep; 66(18):9290-8. PubMed ID: 16982774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
